Esonix 40 mg/vial (IV Injection)

40 mg vial: ৳ 110.00

Medicine Details

Indications

  • Relief from chronic heartburn symptoms and other symptoms associated with GERD
  • Healing of erosive esophagitis
  • Maintenance of healing of erosive esophagitis
  • Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease in combination with amoxicillin and clarithromycin
  • Zollinger-Ellison Syndrome
  • Acid-related Dyspepsia
  • Duodenal & Gastric ulcer

Pharmacology

  • Proton pump inhibitor
  • Inhibits gastric acid secretion
  • Formulated with enteric-coated pellets
  • Peak plasma levels occur at approximately 1.5 hours after oral administration
  • Metabolized in the liver by cytochrome P450 enzyme system

Dosage

  • Healing of erosive esophagitis: 20 mg or 40 mg once daily for 4-8 weeks
  • Symptomatic GERD: 20 mg once daily for 4 weeks
  • Maintenance of Healing of Erosive Esophagitis: 20 mg once daily
  • Helicobacter Pylori eradication: Triple Therapy for 10 days
  • Zollinger-Ellison Syndrome: 20-80 mg once daily
  • Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks
  • Duodenal ulcer: 20 mg once daily for 2-4 weeks, Gastric ulcer: 20-40 mg once daily for 4-8 weeks
  • IV Injection or IV infusion for various conditions based on patient age and weight

Administration

  • Tablet or capsule should be swallowed whole and taken one hour before a meal
  • Proper administration of oral suspension
  • Preparation of IV Injection solution
  • Use of antacids while taking the product

Interaction

  • Metabolized in the liver by CYP2C19 and CYP3A4
  • Unlikely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1, and 3A4
  • Potential interference with the absorption of drugs where gastric pH is important
  • Effects of combination therapy with clarithromycin

Contraindications

  • Contraindicated in patients with known hypersensitivity to any of the formulation

Side Effects

  • Headache
  • Diarrhoea
  • Nausea
  • Flatulence
  • Abdominal pain
  • Constipation
  • Dry mouth

Pregnancy & Lactation

  • No adequate and well-controlled studies in pregnant women
  • No teratogenic effects in animal studies
  • Excretion in milk not studied, breastfeeding should be discontinued if essential

Precautions & Warnings

  • Symptomatic response to therapy does not preclude the presence of gastric malignancy
  • Guidelines for patients with difficulty swallowing capsules

Use in Special Populations

  • Safety and effectiveness not established in paediatric patients
  • No overall differences in safety and efficacy in the elderly
  • No dosage adjustment recommended for patients with mild to moderate hepatic insufficiency
  • Pharmacokinetics not expected to be altered in patients with renal impairment

Overdose Effects

  • Lethal dose in rats
  • Signs of acute toxicity include reduced motor activity, changes in respiratory frequency, tremor, ataxia, and convulsions
  • No specific antidote known, treatment should be symptomatic and supportive

Storage Conditions

  • Store at a temperature not exceeding 30°C in a dry place
  • Protect from light and moisture
  • Keep out of reach of children

Chemical Structure

  • Molecular Formula: C17H19N3O3S
  • Chemical Structure Image: Available

Commonly Asked Questions

  • Information about Esonix 40 mg/vial Injection
  • Uses, side effects, pregnancy/breastfeeding, time to work, and quick tips

Compound Summary

Please refer to the 'Chemical Structure' attribute for details.

Related Brands